Price history
Select outcomes to plot.
Description
FDA moves BPC-157 to Category 1 by the listed date? tracks whether the FDA announces a reclassification to Category 1 (or equivalent) of the Bulk Drug Substances List for BPC-157 by the specified deadlines. A qualifying announcement must be official and public; rumors do not qualify. Reclassification announced by the date resolves Yes; otherwise No. Even if the FDA states future intent to reclassify, that qualifies only if the announcement occurs within the market’s timeframe. Resolution relies on official FDA statements or a credible reporting consensus when needed.
Event stats
24h volume
Total volume
Liquidity
Markets
2
Market highlights
Top market
24h gainer
24h loser
Highest volume
Top market
24h gainer
24h loser
Highest volume
Related events
Will Trump publicly insult someone on...?Who will Trump publicly insult by June 30?Bill Clinton divorce by June 30?Will Trump dance on...?Trump declassifies new UFO files by...?How many World Cup matches will Trump attend?What will Trump say this week? (June 23 - 28)Will Seattle Seahawks visit the White House in 2026?Epstein or Maxwell confirmed Mossad operatives by June 30?SBF released from custody in 2026?
Markets
Outcome | Odds | Spread | 24h Change | 24h Volume | Total Volume | Liquidity | |
|---|---|---|---|---|---|---|---|
| August 31, 2026 | — | — | — | — | — | — | |
| December 31, 2026 | — | — | — | — | — | — |
Rules
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET. Otherwise, this market will resolve to “No”. A qualifying announcement must be official and public. Any rumored or private statements of intention will not qualify. Any announcement that the drug has been reclassified to Category 1 will qualify. Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date. A qualifying reclassification must be to Category 1 of the Bulk Drug Substances List or an equivalent classification that allows interim compounding of the drug. Removal from a different category will not qualify. The resolution source for this market will be official statements from the FDA; however, a consensus of credible reporting will also be used.